Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...
New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company”) announced today that its SomaScan™ Platform played a pivotal role in a study ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...
At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...